SI21101A - Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo - Google Patents
Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo Download PDFInfo
- Publication number
- SI21101A SI21101A SI200100300A SI200100300A SI21101A SI 21101 A SI21101 A SI 21101A SI 200100300 A SI200100300 A SI 200100300A SI 200100300 A SI200100300 A SI 200100300A SI 21101 A SI21101 A SI 21101A
- Authority
- SI
- Slovenia
- Prior art keywords
- lisinopril
- reverse osmosis
- carried out
- concentration
- permeate
- Prior art date
Links
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 title claims abstract description 37
- 229960002394 lisinopril Drugs 0.000 title claims abstract description 36
- 108010007859 Lisinopril Proteins 0.000 title claims abstract description 34
- 238000001223 reverse osmosis Methods 0.000 title claims abstract description 27
- 239000012223 aqueous fraction Substances 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000000746 purification Methods 0.000 claims abstract description 4
- 239000012466 permeate Substances 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000002955 isolation Methods 0.000 abstract description 3
- 239000012528 membrane Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000007040 multi-step synthesis reaction Methods 0.000 description 2
- 238000011020 pilot scale process Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200100300A SI21101A (sl) | 2001-11-26 | 2001-11-26 | Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo |
| AT02778183T ATE338765T1 (de) | 2001-11-26 | 2002-11-08 | Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose |
| DE60214587T DE60214587D1 (de) | 2001-11-26 | 2002-11-08 | Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose |
| AU2002339835A AU2002339835A1 (en) | 2001-11-26 | 2002-11-08 | Concentrating aqueous fractions of lisinopril by reverse osmosis |
| EP02778183A EP1451208B1 (de) | 2001-11-26 | 2002-11-08 | Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose |
| PCT/SI2002/000025 WO2003045981A2 (en) | 2001-11-26 | 2002-11-08 | Concentrating aqueous fractions of lisinopril by reverse osmosis |
| US10/496,780 US20050010056A1 (en) | 2001-11-26 | 2002-11-08 | Concentrating aqueous fractions of lisinopril by reverse osmosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200100300A SI21101A (sl) | 2001-11-26 | 2001-11-26 | Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI21101A true SI21101A (sl) | 2003-06-30 |
Family
ID=20433017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200100300A SI21101A (sl) | 2001-11-26 | 2001-11-26 | Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050010056A1 (de) |
| EP (1) | EP1451208B1 (de) |
| AT (1) | ATE338765T1 (de) |
| AU (1) | AU2002339835A1 (de) |
| DE (1) | DE60214587D1 (de) |
| SI (1) | SI21101A (de) |
| WO (1) | WO2003045981A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101985463A (zh) * | 2010-10-29 | 2011-03-16 | 浙江昌明药业有限公司 | 一种利用膜分离技术分离制备赖诺普利的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
| US5336601A (en) * | 1986-08-18 | 1994-08-09 | The Coca-Cola Company | Enzymatic membrane method for the snythesis and separation of peptides |
| JP3792777B2 (ja) * | 1996-05-10 | 2006-07-05 | 株式会社カネカ | １−アルコキシカルボニル−３−フェニルプロピル誘導体の製造方法 |
| US5907044A (en) * | 1997-07-30 | 1999-05-25 | Degussa Aktiengellschaft | Method of isolating 1- N2 -((S)-ethoxycarbonyl)-3-phenylpropyl)-N6 -trifluoroacetyl!-L-lysyl-L-proline (lisinopril (TFA) ethyl ester, LPE) |
-
2001
- 2001-11-26 SI SI200100300A patent/SI21101A/sl not_active IP Right Cessation
-
2002
- 2002-11-08 EP EP02778183A patent/EP1451208B1/de not_active Expired - Lifetime
- 2002-11-08 WO PCT/SI2002/000025 patent/WO2003045981A2/en not_active Ceased
- 2002-11-08 US US10/496,780 patent/US20050010056A1/en not_active Abandoned
- 2002-11-08 AT AT02778183T patent/ATE338765T1/de not_active IP Right Cessation
- 2002-11-08 AU AU2002339835A patent/AU2002339835A1/en not_active Abandoned
- 2002-11-08 DE DE60214587T patent/DE60214587D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002339835A1 (en) | 2003-06-10 |
| US20050010056A1 (en) | 2005-01-13 |
| EP1451208A2 (de) | 2004-09-01 |
| AU2002339835A8 (en) | 2003-06-10 |
| WO2003045981A3 (en) | 2003-12-24 |
| ATE338765T1 (de) | 2006-09-15 |
| DE60214587D1 (de) | 2006-10-19 |
| EP1451208B1 (de) | 2006-09-06 |
| WO2003045981A2 (en) | 2003-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1230194B1 (de) | Kristallisierung von materialien aus wässerigen lösungen | |
| KR20110112859A (ko) | 전기투석 폐 스트림으로부터의 베타인의 회수 방법 | |
| ES2797379T3 (es) | Procedimiento de purificación de 1,4-diaminobutano, 1,4-diaminobutano purificado por dicho procedimiento, y poliamida preparada a partir de este | |
| JPH1033950A (ja) | 無機固体への吸着により有機化合物を分離するための十字流濾過方法 | |
| SI21101A (sl) | Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo | |
| Shishikura et al. | Separation and purification of organic acids by gas antisolvent crystallization | |
| EP0919540B1 (de) | Verfahren zur Herstellung von gereinigtem kristallinen Iohexol | |
| SK106099A3 (en) | Process for selective enrichment and separation of aroma molecules by adsorption | |
| US10407463B2 (en) | Method for producing alpha-form crystal of reduced glutathione, and method for storing said crystal | |
| EP0781264B1 (de) | Verfahren zur wiedergewinnung von zitronensäure | |
| JPS6049199B2 (ja) | α−Ｌ−アスパルチル−Ｌ−フエニルアラニン低級アルキルエステルの精製法 | |
| US5965028A (en) | Process for treating a liquid | |
| Isono et al. | Hollow-fibre enzyme reactor integrated with solvent extraction for synthesis of aspartame precursor | |
| US20080207944A1 (en) | Method For Separating Compound-Forming Chiral Systems | |
| EP1756055A1 (de) | Verfahren zur aufreinigung von tryptophan | |
| SK62599A3 (en) | Process for the separation of tetrahydropyrimidin derivatives | |
| US10207986B2 (en) | Method for preparing D-arginine | |
| Guell | Membrane separation techniques in wine and beer production | |
| SI20211A (sl) | Postopek za kristaliziranje maleatne soli N-(1(S)-etoksikarbonil-3-fenilpropil)-L-alanil-L-prolina | |
| CN106674037B (zh) | 一种从阿巴斯甜合成母液中分离l-苯丙氨酸的方法 | |
| RU2128187C1 (ru) | Способ извлечения исходных материалов в процессе изготовления аспартама и устройство для его осуществления | |
| KR830001713B1 (ko) | 구아니딘의 제조방법 | |
| DE10047444A1 (de) | Verfahren zur Trennung und hochreinen Isolierung von niedermolekularen, strukturell ähnlichen Verbindungen insbesondere von Tetrahydropyrimidinderivaten wie z.B. 1,4,5,6-Tetrahydro-2-methyl-4-pyrimidincarbonsäuren (Ectoine) und deren Spaltprodukte | |
| JPH06306011A (ja) | ピルビン酸またはその塩の単離法 | |
| JPS63130580A (ja) | トリプトフアンの精製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date | ||
| KO00 | Lapse of patent |
Effective date: 20080818 |